Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi
1946 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
ROVI STOCK SYMBOL
$28.26 SHARE PRICE (As of Friday Closing)
Description

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
XMAD
Primary Office
  • Calle José Isbert, 2
  • 28223 Madrid
  • Spain

+34 910 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Laboratorios Farmaceuticos Rovi’s full profile, request a free trial.

Laboratorios Farmaceuticos Rovi Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$18.98 - $29.48 $1.57B $28.65 $0.66 25.5K 55.4M

Laboratorios Farmaceuticos Rovi Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,306,991 1,130,940 924,747 639,133
Revenue 400,570 357,800 310,867 293,312
EBITDA 58,399 34,718 33,744 43,576
Net Income 37,142 21,117 19,444 28,858
Total Assets 494,725 460,650 357,970 302,730
Total Debt 48,519 39,149 51,872 35,541
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Laboratorios Farmaceuticos Rovi Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Laboratorios Farmaceuticos Rovi‘s full profile, request access.

Request full access to PitchBook

Laboratorios Farmaceuticos Rovi Executive Team (3)

Name Title Board
Seat
Contact
Info
Juan Encina Chief Executive Officer
Javier Encina Chief Financial Officer & Second Vice Chairman
Pablo Jorge Chief Economic and Administrative Officer

Laboratorios Farmaceuticos Rovi Board Members (1)

Name Representing Role Since Contact
Info
000000 000000 Laboratorios Farmaceuticos Rovi Chief Financial Officer & Second Vice Chairman 000 0000